First human tests begin for new experimental injection
NCT ID NCT07232758
Summary
This is an early-stage study to check if a new injectable drug called HRS-2183 is safe and how it moves through the body. It involves 42 healthy Chinese adults who will receive single or multiple doses. The main goal is to monitor for side effects and measure how the drug is absorbed and eliminated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHINESE HEALTHY ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, 250100, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.